Partnerships are powerful in moving from apps to medical devices

December 8, 2014 Erin Righetti


shutterstock_196545512According to PricewaterhouseCooper, one of the top trends to keep an eye on next year in the healthcare field is the evolving role of medical apps moving to medical devices.  Next year, the FDA is set to review hundreds of apps.  But PWC points out that even though they’ve been reviewing these apps for years, only 100 have ever been approved.  As more companies get involved in the field, it will be critical for developers to understand and work towards compliance.  Guidance is expected at some point in 2015, but how can companies develop a compelling case of compliance and usefulness for their apps?  Look for partners.  Medical device companies don’t have the the development expertise that development companies have.  And likewise, development companies aren’t as versed in FDA compliance.

While the market is well saturated, what are some of the key opportunities that developers can tap in the app market for healthcare?

This January, Biotech Showcase™ will look at the opportunities for and value of partnerships in teaming up to create medical device apps in the session Apps as drug. Steve Dickman, the CEO, CBT Advisors will be joined by Eric Elenko, CEO, Akili Interactive Labs and Alex Mian, CEO, Curelator, Inc. to look at the current landscape of apps that could function as medical devices. Biotech Showcase will take place January 12-14, 2015 in San Francisco. For more information and to register for this event, visit the homepage.




Previous Article
Cancer immunotherapies and nano-based delivery approaches sure to be hot topics in 2015

A recent article published in the November 26, 2014 issue of Frontiers In Chemistry magazine discussed the ...

Next Article
The complexity of immuno-oncology trials
The complexity of immuno-oncology trials

The value of developing an immunotherapy has grown over the past few years – as science and technology has ...